Skip to main content
OpenTrials

Clinical trial condition

Bacterial Infections and Mycoses

Explore clinical trials studying Bacterial Infections and Mycoses. Study availability and eligibility vary by location and protocol.

5,909 public trials 639 recruiting studies
Refine in advanced search Browse all conditions

Bacterial Infections and Mycoses trial results

Completed

Diode Laser Treatment of Onychomycosis

NCT01452490

Conditions
Bacterial Infections and Mycoses, Dermatomycoses, Infections, +7 more
Locations
  • Shoreline Foot and Ankle Center New London, Connecticut, United States
  • Shoreline Foot and Ankle Center Westbrook, Connecticut, United States
View Trial Details
Completed

Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects

NCT03311659

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations
  • GSK Investigational Site Barnaul, Russia
  • GSK Investigational Site Gatchina, Russia
  • GSK Investigational Site Moscow, Russia
  • GSK Investigational Site Moscow, Russia
View Trial Details
Completed

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

NCT04208789

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations
  • Kanudjoso Djatiwibowo General Hospital Balikpapan, East Kalimantan, Indonesia
  • Tarakan General Hospital Tarakan, North Kalimantan, Indonesia
  • Wahidin Sudirohusodo General Hospital Makassar, South Sulawesi, Indonesia
  • Labuang Baji General Hospital Makassar, South Sulawesi, Indonesia
View Trial Details
Completed

Molecular Characterization of Candida Auris

NCT04121871

Conditions
Bacterial Infections and Mycoses, Candidiasis, Infections, +2 more
Locations
  • Bahawal Victoria Hospital Bahawalpur Bahawalpur, Punjab Province, Pakistan
  • Civil Hospital Jhangi Wala Road Bahawalpur Bahawalpur, Punjab Province, Pakistan
View Trial Details
Completed

A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years

NCT02531698

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • Helsinki South Vaccine Research Clinic Helsinki, Finland
  • Oulu Vaccine Research Clinic Oulu, Finland
  • Pori Vaccine Research Clinic Pori, Finland
View all 15 locations
View Trial Details

Related conditions